Exact Mass: 353.0367632000001
Exact Mass Matches: 353.0367632000001
Found 114 metabolites which its exact mass value is equals to given mass value 353.0367632000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pentoxazone
C17H17ClFNO4 (353.08300840000004)
Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
2,5-diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one
2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone is a member of the class of compounds known as pentose phosphates. Pentose phosphates are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone can be found in a number of food items such as horned melon, buffalo currant, papaya, and red algae, which makes 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone a potential biomarker for the consumption of these food products. 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone exists in E.coli (prokaryote) and yeast (eukaryote).
2-((4-Methoxy-3-methyl-2-pyridylmethyl)sulfo)-5-trifluoromethyl-1H-benzimidazole
C16H14F3N3OS (353.08096300000005)
5'-Hydroxytenoxicam
5-Hydroxytenoxicam is only found in individuals that have used or taken Tenoxicam. 5-Hydroxytenoxicam is a metabolite of Tenoxicam. 5-hydroxytenoxicam belongs to the family of Thienothiazines. These are heterocyclic compounds containing a thiophene ring fused to a thiazine.
4'-Hydroxy-5-carboxy-lumiracoxib
C16H13ClFNO5 (353.04662500000006)
4-Hydroxy-5-carboxy-lumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)
lansoprazole sulfide
C16H14F3N3OS (353.08096300000005)
lansoprazole sulfide is a metabolite of lansoprazole. Lansoprazole is a proton-pump inhibitor (PPI) which inhibits the stomachs production of gastric acids. It is manufactured by a number of companies worldwide under several brand names. In the United States it was first approved by the Food and Drug Administration (FDA) in 1995. Lansoprazole has been available as a generic drug since Prevacid patent protection expired on November 10, 2009. Since 2009 Lansoprazole has been available over the counter (OTC) in the U.S. (Wikipedia)
Naringenin 5-sulfate
C15H13O8S (353.03311180000003)
2-(O-Tolylcarbamoyl)naphthalen-3-yl 2-chloroacetate
7-(3-Isothiocyanatopyrrolidin-1-yl)-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide
Aceclofenac
C16H13Cl2NO4 (353.02215980000005)
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Clopidogrel thiol
C16H16ClNO2S2 (353.03109459999996)
Daltroban
C16H16ClNO4S (353.04885260000003)
Flosulide
C16H13F2NO4S (353.05333220000006)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
4-(4'-Chlorobenzyloxy)benzyl nicotinate
Syk Inhibitor
C18H15N3O3S (353.0834080000001)
Diethyl 3-methyl-5-[(trifluoroacetyl)amino]-2,4-thiophenedicarboxylate
Aceclofenac
C16H13Cl2NO4 (353.02215980000005)
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents CONFIDENCE standard compound; INTERNAL_ID 1161
Pyrazolam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators
N-(2-Cyanoethyl)-N-(2-thienylmethyl)-N-[3-(trifluoromethyl)phenyl]urea
C16H14F3N3OS (353.08096300000005)
PharmaGSID_48505
CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4776; ORIGINAL_PRECURSOR_SCAN_NO 4773 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4805; ORIGINAL_PRECURSOR_SCAN_NO 4803 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4769; ORIGINAL_PRECURSOR_SCAN_NO 4767 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4827; ORIGINAL_PRECURSOR_SCAN_NO 4826 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9149; ORIGINAL_PRECURSOR_SCAN_NO 9147 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9178; ORIGINAL_PRECURSOR_SCAN_NO 9177 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9199; ORIGINAL_PRECURSOR_SCAN_NO 9197 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9243; ORIGINAL_PRECURSOR_SCAN_NO 9240 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9247 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9249
(-)-Eudistomin K|Eudistomin K|eudistomin K trifluoroacetate
C14H16BrN3OS (353.01973860000004)
Famotidine sulfoxide
C8H15N7O3S3 (353.03984800000006)
2-[1-(4-methoxyphenyl)-4-nitro-3-thiophen-2-ylbutylidene]propanedinitrile
C18H15N3O3S (353.0834080000001)
4-[[4-(dimethylamino)phenyl]carbamoylamino]benzenesulfonyl chloride
2-(2-CHLORO-ACETYLAMINO)-4-(4-METHOXY-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
C16H16ClNO4S (353.04885260000003)
Thiazolidine, 3-[(4-chlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
C16H16ClNO2S2 (353.03109459999996)
(S)-(+)-ALPHA-METHYL-1H-IMIDAZOLE-4-ETHANAMINEDIHYDROBROMIDE
(1Z)-4-chloro-3-sulfamoyl-N-(2,4,6-trimethylpyridin-1-ium-1-yl)benzenecarboximidate
4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide
Buthiazide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
4-[3-(4-CARBAMOYL-PHENYL)UREIDO]BENZENESULFONYLCHLORIDE
C14H12ClN3O4S (353.02370220000006)
4-((2-AMINOPHENYL)THIO)-N,N-DIMETHYL-3-NITROBENZENESULFONAMIDE
Diethyl thiophosphoril (Z)-(2-aminothiazol-4-yl)-(methoxyimino)acetate
(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(2-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID
Ibacitabine
C9H12IN3O4 (352.98725420000005)
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
4-(Phenylamino)-3-sulfoazobenzene
C18H15N3O3S (353.0834080000001)
2-Butenoic acid,4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-, (2Z)-
2-Methyl-2-propanyl 5-bromo-3-[(dimethylamino)methyl]-1H-pyrrolo[ 2,3-b]pyridine-1-carboxylate
C15H20BrN3O2 (353.07388000000003)
Quinfamide
C16H13Cl2NO4 (353.02215980000005)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
5,7-BIS(TRIFLUOROMETHYL)-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
C14H9F6NO3 (353.04865960000006)
bis(triphenylphosphine)iminium nitrite
[(C6H5)3P=]2N(ONO) (353.06087299999996)
Daltroban
C16H16ClNO4S (353.04885260000003)
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C26170 - Protective Agent > C2079 - Cardioprotective Agent
N7-(3-CHLOROPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE
C17H12ClN5S (353.05019020000003)
4-CHLORO-2-TRIFLUOROACETYL-6-(TERT-BUTYLDIMETHYLSILYLOXY)ANILINE
2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluoro-phe noxy]acetic acid
C16H13ClFNO5 (353.04662500000006)
Dabuzalgron hydrochloride
C12H17Cl2N3O3S (353.0367632000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1-methylsulfanyl-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]benzimidazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
C16H14F3N3OS (353.08096300000005)
Glionitrin A
A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring. It is an antibiotic isolated from the microbial strains Sphingomonas and Aspergillus fumigatus, and exhibits cytotoxic activity against four human cancer cell lines: HCT-116, A549, AGS, and DU145. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines
3-(2-Pyrimidinylthio)-1-[2-(trifluoromethyl)phenyl]pyrrolidine-2,5-dione
7,9-dimethyl-2-(phenylmethylthio)-1H-pyrido[2,3]thieno[2,4-b]pyrimidin-4-one
2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-N-(5-hydroxy-2-pyridinyl)-2-methyl-, 1,1-dioxide
5-(Hydroxymethyl)cytidine 5-(Dihydrogen Phosphate)
2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(methyldisulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
anthraquinone-2-carboxyate-N-acetylcysteamine
C19H15NO4S (353.0721750000001)
methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-2-sulfanylacetate
C16H16ClNO2S2 (353.03109459999996)
1-(2,4-Difluorophenyl)-5-[[[methylamino(sulfanylidene)methyl]hydrazinylidene]methyl]-4-pyrazolecarboxylic acid methyl ester
1-[(E)-[5-(2,5-dichlorophenyl)furan-2-yl]methylideneamino]-3-prop-2-enylthiourea
C15H13Cl2N3OS (353.01563480000004)
Methyl 2-[(4-chloro-1-methylpyrazole-3-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
1-(2-Methoxyethyl)-3-[(E)-1-(2,3,4-trichlorophenyl)ethylideneamino]thiourea
C12H14Cl3N3OS (352.99231240000006)
Glu-Cys-Cys
A tripeptide composed of one L-glutamic acid and two L-cysteine units joined by peptide linkages.
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide
C14H16BrN3OS (353.01973860000004)
2-[[(3,5-Dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid
C16H13Cl2NO4 (353.02215980000005)
N-[(4-chlorophenyl)methyl]-4-(2-furanyl)-6-(trifluoromethyl)-2-pyrimidinamine
3-amino-N-(2-fluorophenyl)-6-(2-furanyl)-2-thieno[2,3-b]pyridinecarboxamide
C18H12FN3O2S (353.06342240000004)
3-[(3,5-Dichloro-4-ethoxybenzoyl)amino]benzoic acid
C16H13Cl2NO4 (353.02215980000005)
2-[(4,6-Dioxo-2-thioxo-tetrahydro-pyrimidin-5-ylidenemethyl)-amino]-5-ethyl-thiophene-3-carboxylic acid ethyl ester
1-(3-Chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea
1-(4-Chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole
C14H12ClN3O4S (353.02370220000006)
5-(2-chlorophenyl)-2-(2-pyridinylmethyl)-3H-thieno[2,3-d]pyrimidin-4-one
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3,3,3-trifluoro-2-methyl-2-(trifluoromethyl)propanamide
3-[(S)-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfinyl]-N-sulfamoylpropanimidamide
C8H15N7O3S3 (353.03984800000006)
3,4,5-trihydroxy-6-(4-hydroxy-1H-indole-3-carbonyl)oxyoxane-2-carboxylic acid
2,5-diamino-4-hydroxy-6-(5-phosphoribosylamino)pyrimidine
B 823-08
C16H14F3N3OS (353.08096300000005)
2,5-Diamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5-phosphate
5-O-Phosphono-beta-D-ribofuranose in which the hydroxy group at position 1 is substituted by the 6-amino group of 2,5,6-triaminopyrimidin-4(3H)-one.
2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)
The dianion resulting from the removal of two protons from the phosphate group of 2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate.
UBP310
C14H15N3O6S (353.06815300000005)
UBP310 is a selective GluR5 antagonist, with a Kd of 130 nM[1].